TokenPost topic
drug discovery
7 TokenPost stories are tagged drug discovery. The newest appear first.
Latest drug discovery stories
- OpenAI’s MedChemBench Scores GPT-6.2 Astra at 84.5%
The benchmark evaluates 99 drug discovery problems across molecular structures, evidence-based reasoning, compound selection and property predictions.
· Technology
- Bitwise Files for AI Drug Discovery ETF Focused on Medicine Development
The proposed fund would target AI applications in drug development. Bitwise previously proposed AI funds focused on network defense and bonds.
· Investing
- Anthropic Acquires Mithril Medicine to Expand Drug Discovery Work
Mithril founder Cody Tranbarger has joined Anthropic, where the research includes two programs targeting rare forms of muscular dystrophy.
· Business
- OpenAI Uses GPT-Rosalind Agents to Analyze Mouse-Brain Atlas in 32 Minutes
The atlas covers about 7.7 million cells and 1,947 disease-associated genes; proposed biological links still require laboratory testing.
· Technology
- Sam Altman hopes AI will identify a major disease treatment candidate within years
Sam Altman hopes AI will identify a major disease treatment candidate within the next couple of years, though testing and regulatory review would still take time.
· AI
- Anthropic’s Claude Yields 17 Scorpion Toxin Binders in Lab Tests
The 211 designs targeted five neurotoxins. None of the designs intended to target multiple toxins met the criteria for binding more than one.
· Technology
- NVIDIA, Eli Lilly Plan Up to $1 Billion for AI Drug Lab
The five-year partnership will link Lilly’s wet labs with computational systems and use NVIDIA’s BioNeMo platform and planned Vera Rubin architecture.
· Business